@article{b83e3e2c27f049509539a261871677e5,
title = "CanSAR: Update to the cancer translational research and drug discovery knowledgebase",
abstract = "canSAR (http://cansar.icr.ac.uk) is a public, freely available, integrative translational research and drug discovery knowlegebase. canSAR informs researchers to help solve key bottlenecks in cancer translation and drug discovery. It integrates genomic, protein, pharmacological, drug and chemical data with structural biology, protein networks and unique, comprehensive and orthogonal 'druggability' assessments. canSAR is widely used internationally by academia and industry. Here we describe major enhancements to canSAR including new and expanded data. We also describe the first components of canSARblack-an advanced, responsive, multi-device compatible redesign of canSAR with a question-led interface.",
author = "Coker, {Elizabeth A.} and Costas Mitsopoulos and Tym, {Joesph E.} and Angeliki Komianou and Christos Kannas and {Di Micco}, Patrizio and {Villasclaras Fernandez}, Eloy and Bugra Ozer and Antolin, {Albert A.} and Paul Workman and Bissan Al-Lazikani",
note = "Funding Information: canSAR is funded by the Cancer Research UK Drug Discovery Committee strategic award 'canSAR: enhancing the drug discovery knowledgebase' [C35696/A23187]. Paul Workman and Bissan Al-Lazikani are funded by the Institute of Cancer Research. Costas Mitsopoulos and Bugra Ozer are funded by Cancer Research UK core funding to the ICR's CRUK Cancer Therapeutic Unit [C309/A25144]. Funding for open access charge: The Charity Open Access Fund. Albert A. Antolin is a Henry Wellcome Research Fellow [204735/Z/16/Z]. Publisher Copyright: {\textcopyright} The Author(s) 2018.",
year = "2019",
month = jan,
day = "8",
doi = "10.1093/nar/gky1129",
language = "English (US)",
volume = "47",
pages = "D917--D922",
journal = "Nucleic acids research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "D1",
}